BioCentury
ARTICLE | Company News

Mesoblast, Osiris deal

April 14, 2014 7:00 AM UTC

Osiris said it received $15 million in cash from Mesoblast under a 2013 deal in which Mesoblast acquired Osiris' culture-expanded mesenchymal stem cell (MSC) business. Last year, Osiris received a $15...